Study of Cir Q- Life suga balanz capsule on decreasing levels of blood glucose,serum lipid and acute toxicity
-
摘要: 目的:观察Cir Q-Life糖衡素(CSB)胶囊对2型糖尿病(T2DM)大鼠辅助降糖降脂功能及急性毒性。方法:采用高脂高糖饲料喂养结合小剂量链脲佐菌素腹注,复制T2DM模型。SD大鼠按空腹血糖和给2.5 g/kg葡萄糖后0.5 h血糖值分成阴性组、模型组和低、中、高(75、150、300 mg/kg·BW)3个CSB胶囊组。3个剂量组每天灌胃CSB,5周后检测大鼠空腹血糖、糖耐量、血脂、血清胰岛素;采用最大耐受量法(MTD),观察其急性毒性。结果:与模型组比较,CSB胶囊高剂量组可明显降低大鼠空腹血糖(p<0.05),糖耐量虽有一定的改善,但差异无统计学意义;对血清胰岛素及胆固醇水平无影响,但CSB胶囊三个剂量组均能使血清甘油三酯显著降低(p<0.05)。CSB胶囊一次性灌胃给样,对小鼠MTD>26.0 g/kg·BW,为无毒级物质。结论:CSB胶囊具有辅助性降血糖及降低甘油三酯的作用。Abstract: Objective: To observe the assistant effects of Cir Q- Life suga balanz( CSB) capsules on decreasing the levels of blood glucose and serum lipid in type 2 diabetes mellitus( T2DM) rats and acute toxicity in mice.Methods:T2DM models were built with the method of higher lipid and sugar diets and injection of a low dose of streptozotocin.Rats were divided into normal group,model group and the low,middle,high dose( 75,150,300 mg · kg- 1·BW) of CSB capsules groups.Three dose groups rats were administrated with CSB capsules per day for 5 weeks.The fasting blood glucose( FBG),serum lipid,serum insulin( INS) were tested. The acute toxicity of CSB capsules was investigated by the maximum toxicity dose( MTD) method. Result: Compared with model group,the FBG in high dose of CSB capsules group was decreased significantly( p < 0.05),and the glucose tolerance presents showed certain changes,but the difference was not statistically significant.The serum INS levels and serum cholesterol( TC) levels did not significantly change,but the serum triglyceride( TG) was reduced obviously( p < 0.05) in three dose of CSB capsules groups compared to the model group. The daily MTD of CSB capsules in mice was26.0 g / kg·BW which was innocuous substance.Conclusion: CSB capsules has assistant effects for decreasing levels of FBG and TG in T2 DM rats.
-
Keywords:
- CSB /
- T2DM /
- blood glucose /
- serum lipid /
- acute toxicity
-
[1] 刘子琪,刘爱萍,王培玉.中国糖尿病患病率的流行病学调查研究状况[J].中华老年多器官疾病杂志,2015,14(7):547-550. [2] Zhang L-J,Liaw C-C,Hsiao P-C,et al.Cucurbitane-type glycosides from the fruits of Momordica charantia and their hypoglycaemic and cytotoxic activities[J].Journal of Functional Foods,2014,6(1):564-574.
[3] 马春宇,于洪宇,王慧娇,等.苦瓜总皂苷对2型糖尿病大鼠降血糖作用机制的研究[J].天津医药,2014,42(4):321-324. [4] 杨静玉,王春明,侯悦,等.苦瓜乙醇提取物对肥胖大鼠糖代谢和内脏脂肪的影响[J].中草药,2012,43(10):2002-2007. [5] 李唯佳,王绪平,俞忠明,等.肉桂挥发油对糖尿病大鼠血糖、血脂的影响[J].中国中医药科技,2012,19(l):37-38. [6] 陈斌,钱骅,赵伯涛,等.人参和西洋参对糖尿病作用的研究进展[J].人参研究,2011,23(1):33-36. [7] 王晶,张天英,胡洋,等.西洋参皂苷对大鼠实验性高血脂的影响分析[J].黑龙江医药科学,2015(6):125-126. [8] 丁红,王颜,于亚鹭,等.牛初乳粉对实验性糖尿病的作用[J].卫生研究,2006(5):579-580. [9] 刘姣,田义龙,李琛,等.淡豆豉异黄酮浓缩物对大鼠胰岛素抵抗的改善作用[J].食品工业科技,2012,33(10):347-348. [10] 林心君,范世明,高长花,等.姜黄素逆转肥胖模型大鼠胰岛素抵抗研究[J].福建中医药大学学报,2013,23(6):23-26. [11] 连冠,鱼毛毛,徐璐,等.葡萄籽多酚降血脂及抗动脉粥样硬化的作用及机制[J].中国动脉硬化杂志,2015(2):121-126. [12] 程玥,陈淑娴,张雪,等.姜黄素对2型糖尿病肾病大鼠肾脏的保护作用[J].陕西中医,2015(1):115-117. [13] 鲍雷,张召锋,戴小倩,等.葡萄籽原花青素对大鼠2型糖尿病肾病的影响[J].现代预防医学,2013(4):622-624.
计量
- 文章访问数: 205
- HTML全文浏览量: 9
- PDF下载量: 77